Nicoletta Sacchi

Personal Home Page

http://www.roswellpark.org/Research/Research_Staff/Sacchi_Nicoletta_PhD

Articles in Scholarly Journals [Incomplete List]

  1. Resveratrol impairs the formation of MDA-MB-231 multicellular tumor spheroids concomitant with ceramide accumulation
    Cancer Letters, vol. 249, no. 2, pp. 143–147, 2007
  2. BMC Genomics, vol. 8, no. 1, p. 38, 2007
  3. Disruption of Retinoic Acid Receptor Alpha Reveals the Growth Promoter Face of Retinoic Acid
    PLoS ONE, vol. 2, no. 9, p. e836, 2007
  4. The single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction: twenty-something years on
    Nature Protocols, vol. 1, no. 2, Article ID nprot.2006.83, 4 pages, 2006
  5. Thymoglobulin Prevents Chronic Graft-versus-Host Disease, Chronic Lung Dysfunction, and Late Transplant-Related Mortality: Long-Term Follow-Up of a Randomized Trial in Patients Undergoing Unrelated Donor Transplantation
    Biology of Blood and Marrow Transplantation, vol. 12, no. 5, pp. 560–565, 2006
  6. RAR-mediated epigenetic control of the cytochrome P450 Cyp26a1 in embryocarcinoma cells
    Oncogene, vol. 25, no. 9, Article ID 1209173, 7 pages, 2006
  7. A Repressive Epigenetic Domino Effect Confers Susceptibility to Breast Epithelial Cell Transformation: Implications for Predicting Breast Cancer Risk
    Cancer Research, vol. 66, no. 21, pp. 10308–10314, 2006
  8. Journal of Medicinal Chemistry, vol. 48, no. 22, pp. 6783–6786, 2005
  9. In vivo imaging of retinoic acid receptor ß2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells
    The Prostate, vol. 64, no. 1, pp. 20–28, 2005
  10. Myeloid maturation block by AML1-MTG16 is associated with Csf1r epigenetic downregulation
    Oncogene, vol. 24, no. 34, Article ID 1208651, 7 pages, 2005
  11. Impaired Retinoic Acid (RA) Signal Leads to RAR 2 Epigenetic Silencing and RA Resistance
    Molecular and Cellular Biology, vol. 25, no. 23, pp. 10591–10603, 2005
  12. The MTG proteins: chromatin repression players with a passion for networking
    Genomics, vol. 84, no. 1, pp. 1–9, 2004
  13. Very High Frequency of Hypermethylated Genes in Breast Cancer Metastasis to the Bone, Brain, and Lung
    Clinical Cancer Research, vol. 10, no. 9, pp. 3104–3109, 2004
  14. Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling
    The FASEB Journal, 2003
  15. Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission
    Bone Marrow Transplantation, vol. 32, no. 3, Article ID 1704132, 6 pages, 2003
  16. The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies
    Oncogene, vol. 21, no. 43, Article ID 1205882, 9 pages, 2002
  17. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)
    Blood, vol. 98, no. 10, pp. 2942–2947, 2001
  18. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR
    The Lancet, vol. 357, no. 9265, pp. 1335–1336, 2001
  19. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor ß2 promoter in breast cancer cells
    Oncogene, vol. 19, no. 12, pp. 1556–1563, 2000
  20. Atrophin-1, the Dentato-rubral and Pallido-luysian Atrophy Gene Product, Interacts with ETO/MTG8 in the Nuclear Matrix and Represses Transcription
    The Journal of Cell Biology, vol. 150, no. 5, pp. 939–948, 2000
  21. Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin
    Bone Marrow Transplantation, vol. 26, no. 12, pp. 1305–1311, 2000
  22. Oligomerization properties of fragile-X mental-retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P
    Biochemical Journal, vol. 343, no. 3, p. 517, 1999
  23. Interphase cytogenetics of the t(8;21)(q22;q22) associated with acute myelogenous leukemia by two-color fluorescence in situ hybridization
    Cancer Genetics and Cytogenetics, vol. 79, no. 2, pp. 97–103, 1995
  24. Erratum
    Cancer Genetics and Cytogenetics, vol. 66, no. 1, p. 81, 1993
  25. High efficiency in the attribution of parental origin of non-disjunction in trisomy 21 by both cytogenetic and molecular polymorphisms
    Human Genetics, vol. 79, no. 2, pp. 124–127, 1988
  26. The ETS genes on chromosome 21 are distal to the breakpoint of the acute myelogenous leukemia translocation (8;21)
    Genomics, vol. 3, no. 2, pp. 110–116, 1988
  27. Lack of Evidence for Association of Meiotic Nondisjunction with Particular DNA Haplotypes on Chromosome 21
    Proceedings of the National Academy of Sciences, vol. 85, no. 13, pp. 4794–4798, 1988
  28. Comparative Mapping of DNA Markers from the Familial Alzheimer Disease and Down Syndrome Regions of Human Chromosome 21 to Mouse Chromosomes 16 and 17
    Proceedings of the National Academy of Sciences, vol. 85, no. 16, pp. 6032–6036, 1988
  29. Human ETS2 Gene on Chromosome 21 is not Rearranged in Alzheimer disease
    Proceedings of the National Academy of Sciences, vol. 85, no. 20, pp. 7675–7679, 1988
  30. The ets Genes in Cells and Viruses: Implications for Leukemias and Other Human Diseases
    Annals of the New York Academy of Sciences, vol. 511, no. 1 Normal and Ne, pp. 171–191, 1987
  31. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
    Analytical Biochemistry, vol. 162, no. 1, pp. 156–159, 1987
  32. Hu-ets-2 is translocated to chromosome 8 in the t(8;21) in acute myelogenous leukemia
    Cancer Genetics and Cytogenetics, vol. 23, no. 3, pp. 269–274, 1986
  33. Oncogenes: Molecular probes for clinical application in malignant diseases
    Gene Analysis Techniques, vol. 3, no. 2, pp. 25–39, 1986
  34. Basic Science Review: The Cellular ets Genes: Molecular Biology and Clinical Implications in Human Leukemias
    Cancer Investigation, vol. 4, no. 6, pp. 555–574, 1986
  35. Phorbol ester-induced changes in human leukemic pre-B lines
    Cellular Immunology, vol. 84, no. 1, pp. 65–73, 1984
  36. DNA synthesis catalyzed in vitro by yeast extracts using A 2 ?m DNA containing plasmid as template for enzymatic DNA synthesis
    Current Genetics, vol. 6, no. 1, pp. 47–54, 1982
  37. Polypeptide structure of human terminal transferase
    Biochemical and Biophysical Research Communications, vol. 108, no. 3, pp. 1196–1203, 1982
  38. A duplication-deficiency X chromosome in a girl with severe mental retardation
    Human Genetics, vol. 54, no. 2, pp. 279–281, 1980
  39. Intercellular exchange of lysosomal hydrolases between mutant human fibroblasts and other cell types
    Experimental Cell Research, vol. 129, no. 2, pp. 383–392, 1980
  40. Chromosome lesions in amniotic fluid cell cultures
    Human Genetics, vol. 49, no. 3, pp. 327–332, 1979
  41. Effect of streptolydigin on chromosome complements of human cells cultured in vitro
    Mutation Research/Genetic Toxicology, vol. 29, no. 2, p. 282, 1975